FDA Oncology Announcements

Anti-RANKL × Clear all

3 Announcements

FDA Approves Denosumab

Drug: Xgeva (denosumab) · Anti-RANKL antibody

Denosumab (Prolia)

Drug: Prolia (denosumab) · Anti-RANKL antibody

Denosumab

Drug: Xgeva (denosumab) · Anti-RANKL antibody